AngioDynamics expected to post 11-cent-per-share loss, revenue seen up 6.3%
LSEG mean estimate points to revenue of $80.5 million for the quarter ending Aug. 31, 2026, versus $75.71 million a year ago. Analyst estimate was unchanged over the past three months.